Glioblastoma is a common and aggressive type of primary brain tumor. Several anticancer drugs affect GBM (glioblastoma multiforme) cells on cell growth and morphology. Taxol is one of the widely used antineoplastic drugs against many types of solid tumors, such as breast, ovarian, and prostate cancers. However, the effect of taxol on GBM cells remains unclear and requires further investigation.
Pubmed ID: 26665000 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets GAPDH antibody produced in mouse
View all literature mentionsThis monoclonal targets Cnp
View all literature mentionsThis monoclonal targets GFAP
View all literature mentionsThis polyclonal targets beta-Tubulin III antibody produced in rabbit
View all literature mentionsThis polyclonal targets beta-Tubulin III antibody produced in rabbit
View all literature mentionsThis monoclonal targets Cnp
View all literature mentionsThis monoclonal targets GAPDH antibody produced in mouse
View all literature mentionsThis monoclonal targets GFAP
View all literature mentions